Table 1.

Prohibited concomitant medications

Treatments prohibited within 7 days of starting the study
● Any antibiotic	● Topical corticosteroids
● Drugs interfering with CsA such as ketoconazole, itraconazole, miconazole, phenobarbital.
Treatments prohibited within 14 days of starting the study
● Cylosporine A	● Systemic short acting glucocorticosteroids, including ophthalmic and otic preparations
● Antihistamines	● Non-steroidal anti-inflammatory drugs (NSAIDs)
● Topical calcineurin inhibitors	● Shampoos (except where the same treatment regimen is maintained throughout the study).
● Vaccination	● Clomipramine, amitriptyline and fluoxetine and any other serotonin reuptake inhibitor
Other prohibited treatments
● Allergen specific immunotherapy (except if initiated for at least 9 months and where the same treatment regimen is maintained throughout the study).
● Treatment with systemic long-acting corticosteroids within the last 3 months
● Essential fatty acids except those used before study initiation for at least 57 days and where the same treatment regime is maintained throughout the study